TARGET PharmaSolutions

News

Published On: 8/15/2019

Executive Voice: She keeps the Triangle on target in life sciences

We would like to congratulate Meg Powell, our Co-Founder and current Board Chair, on her recent Q&A feature article with the Triangle Business Journal.

 

https://www.bizjournals.com/triangle/news/2019/08/15/executive-voice-she-keeps-the-triangle-on-target.html

About TARGET PharmaSolutions

Headquartered in Durham, NC, TARGET PharmaSolutions is a privately held real-world data solutions company that provides pharmaceutical and biotechnology partners a more efficient way to generate data in the real-world setting.  TARGET PharmaSolutions has six disease communities: TARGET-NASH (nonalcoholic steatohepatitis), TARGET-PBC (primary biliary cholangitis), TARGET-HCC (hepatocellular carcinoma), TARGET-IBD (inflammatory bowel disease), TARGET-DERM (immune mediated skin conditions) and TARGET-HBV (hepatitis B).

For more information, visit www.targetpharmasolutions.com.

Contact:

Matt Casbon
Chief Business Officer

MCasbon@TargetPharmaSolutions.com

984.234.0268 ext 226